PP
ETNB

PDT Partners’s 89bio ETNB Stock Holding History

PDT Partners’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-66,088
Closed -$480K – 729
2025
Q1 		$480K Sell
66,088
-14,830
-18% -$130K 0.03% 533
2024
Q4 		$633K Sell
80,918
-88,327
-52% -$727K 0.06% 430
2024
Q3 		$1.25M Buy
+169,245
New +$1.42M 0.11% 320
2022
Q3 		– Sell
-10,274
Closed -$33K – 910
2022
Q2 		$33K Sell
10,274
-13,099
-56% -$39.5K ﹤0.01% 927
2022
Q1 		$88K Buy
+23,373
New +$151K 0.01% 875

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PDT Partners's ETNB Position: Q2 2025 in Review

PDT Partners sold out of 89bio (ETNB) in Q2 2025, closing a stake of 66,088 shares — an estimated $480K sold.

PDT Partners first reported a position in ETNB in Q1 2022 and held it in 5 quarters. The position peaked at $1.25M in Q3 2024. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • PDT Partners reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 66,088 89bio shares in Q2 2025, an estimated $480K.
  • PDT Partners first reported a position in 89bio in Q1 2022 and held it in 5 quarters.
  • PDT Partners's 89bio position peaked at $1.25M in Q3 2024.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.